Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 1
2005 2
2006 2
2010 3
2011 2
2012 6
2013 1
2014 3
2015 3
2016 2
2017 4
2018 5
2019 3
2020 3
2021 5
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Results by year

Filters applied: . Clear all
Page 1
Forkhead Box I1 in Breast Carcinoma as a Potent Prognostic Factor.
Onodera Y, Takagi K, Neoi Y, Sato A, Yamaguchi M, Miki Y, Ebata A, Miyashita M, Sasano H, Suzuki T. Onodera Y, et al. Acta Histochem Cytochem. 2021 Aug 25;54(4):123-130. doi: 10.1267/ahc.21-00034. Epub 2021 Jul 31. Acta Histochem Cytochem. 2021. PMID: 34511651 Free PMC article.
Publisher Correction: Enhancer remodeling promotes tumor-initiating activity in NRF2-activated non-small cell lung cancers.
Okazaki K, Anzawa H, Liu Z, Ota N, Kitamura H, Onodera Y, Alam MM, Matsumaru D, Suzuki T, Katsuoka F, Tadaka S, Motoike I, Watanabe M, Hayasaka K, Sakurada A, Okada Y, Yamamoto M, Suzuki T, Kinoshita K, Sekine H, Motohashi H. Okazaki K, et al. Among authors: onodera y. Nat Commun. 2021 Jan 15;12(1):506. doi: 10.1038/s41467-021-20927-9. Nat Commun. 2021. PMID: 33452248 Free PMC article. No abstract available.
Enhancer remodeling promotes tumor-initiating activity in NRF2-activated non-small cell lung cancers.
Okazaki K, Anzawa H, Liu Z, Ota N, Kitamura H, Onodera Y, Alam MM, Matsumaru D, Suzuki T, Katsuoka F, Tadaka S, Motoike I, Watanabe M, Hayasaka K, Sakurada A, Okada Y, Yamamoto M, Suzuki T, Kinoshita K, Sekine H, Motohashi H. Okazaki K, et al. Among authors: onodera y. Nat Commun. 2020 Nov 20;11(1):5911. doi: 10.1038/s41467-020-19593-0. Nat Commun. 2020. PMID: 33219226 Free PMC article.
Significance of glucocorticoid signaling in triple-negative breast cancer patients: a newly revealed interaction with androgen signaling.
Kanai A, McNamara KM, Iwabuchi E, Miki Y, Onodera Y, Guestini F, Khalid F, Sagara Y, Ohi Y, Rai Y, Yamaguchi R, Tanaka M, Miyashita M, Ishida T, Sasano H. Kanai A, et al. Among authors: onodera y. Breast Cancer Res Treat. 2020 Feb;180(1):97-110. doi: 10.1007/s10549-020-05523-7. Epub 2020 Jan 27. Breast Cancer Res Treat. 2020. PMID: 31989378
The crosstalk between aldosterone and calcium metabolism in primary aldosteronism: A possible calcium metabolism-associated aberrant "neoplastic" steroidogenesis in adrenals.
Gao X, Yamazaki Y, Tezuka Y, Onodera Y, Ogata H, Omata K, Morimoto R, Nakamura Y, Satoh F, Sasano H. Gao X, et al. Among authors: onodera y. J Steroid Biochem Mol Biol. 2019 Oct;193:105434. doi: 10.1016/j.jsbmb.2019.105434. Epub 2019 Jul 24. J Steroid Biochem Mol Biol. 2019. PMID: 31351131
45 results